Related by context. All words. (Click for frequent words.) 86 Improves Survival 85 Improved Survival 84 Antitumor Activity 83 Statistically Significant 83 Prolongs Survival 83 Renal Cell Carcinoma 82 Elderly Patients 82 Rheumatoid Arthritis Patients 82 Colorectal Cancer Patients 82 Advanced Prostate Cancer 82 Adjuvant Chemotherapy 82 Improves Outcomes 81 Advanced Melanoma 81 Newly Diagnosed Multiple Myeloma 81 Meets Primary Endpoint 81 Significantly Reduced 81 Previously Treated 81 Patients Treated 81 Improve Survival 81 Clinical Trial Results 81 Multiple Myeloma Patients 80 Myeloma Patients 80 Study Showed 80 Prostate Cancer Patients 80 Patients Receiving 80 HER2 Positive Breast Cancer 80 Anti Tumor Activity 80 Unfractionated Heparin 80 Advanced Ovarian Cancer 80 Investigational Agent 80 Pooled Analysis 80 Combination Treatment 80 Cardiovascular Events 80 Statin Therapy 79 Well Tolerated 79 Investigational Compound 79 Patients Treated With 79 Previously Untreated 79 Pediatric Patients 79 Disease Progression 79 Obese Patients 79 Cholesterol Lowering Drug 79 Adjuvant Therapy 79 Patients Undergoing 79 Long Term Survival 79 Chronic Hepatitis C 79 Metastatic Colorectal Cancer 79 Combo Therapy 79 Breast Cancer Treatment 79 Appears Safe 79 Relapsed Multiple Myeloma 79 JAK Inhibitor 79 Phase 2b Clinical Trial 79 Drug Shows Promise 79 Drug Candidate 79 Kidney Transplant Patients 79 Lung Cancer Survival 79 Advanced Colorectal Cancer 78 Drug Combo 78 Survival Rates 78 Lung Cancer Patients 78 Postmenopausal Women 78 Anticancer Activity 78 Fewer Side Effects 78 Treatment Naive Patients 78 Phase III Trial 78 Patients Suffering 78 Knee Osteoarthritis 78 Epilepsy Drug 78 Breast Cancer Recurrence 78 Lupus Drug 78 Subgroup Analysis 78 Hypertensive Patients 78 Bare Metal Stents 78 Heart Failure Patients 78 Treated Patients 78 Infected Patients 78 Adjuvant Treatment 78 Shows Efficacy 78 Is Well Tolerated 78 Metastatic Prostate Cancer 78 Fracture Risk 78 Monotherapy 77 Localized Prostate Cancer 77 Relapsing Multiple Sclerosis 77 Breast Tumors 77 Preclinical Data 77 Chemotherapy Regimen 77 Hormone Refractory Prostate Cancer 77 Reduced Risk 77 FDA Okays 77 Metastatic Renal Cell Carcinoma 77 Gene Variant 77 Hormone Receptor Positive 77 Breast Cancer Patients 77 Effective Than 77 Investigational Drug 77 Preclinical Study 77 Slow Progression 77 Premenopausal Women 77 Proves Effective 77 Phase III Trials 77 Osteoporosis Drug 77 Gene Mutation 77 Versus Placebo 77 FDA Approvals 77 Gene Linked 77 Demonstrates Significant 77 Myelodysplastic Syndromes 77 Significant Improvement 77 Androgen Deprivation Therapy 77 Clinical Trial Data 77 Present Preclinical Data 77 Resistant Hypertension 77 Dose Escalation 77 Cancer Recurrence 77 Anti Tumor 77 Severe Sepsis 76 Data Suggest 76 Phase IIb Trial 76 Phase 2b Trial 76 Gene Variation 76 Predict Risk 76 Neoadjuvant Chemotherapy 76 Study Evaluating 76 Cholesterol Drugs 76 Chemotherapy Improves 76 Ovarian Cancer Patients 76 Low Dose 76 Single Dose 76 Clinical Outcome 76 Gastric Cancer 76 Diabetic Patients 76 Increased Risk 76 Lung Cancer Drug 76 Proven Effective 76 Inhaled Corticosteroids 76 Tumor Growth 76 Patient Enrollment 76 Significant Reduction 76 Brain Metastases 76 Aggressive Prostate Cancer 76 Kidney Function 76 Long Term Efficacy 76 Radical Prostatectomy 76 Chemoradiation 76 Newly Diagnosed 76 Blood Pressure Drug 76 HCV Protease Inhibitor 76 Osteoporosis Treatment 76 Efficacious 76 Combination Therapy 76 Gene Mutations 76 Phase 2b Study 76 Overactive Bladder 76 Advanced Pancreatic Cancer 76 Lowers Risk 76 Mouse Model 76 Drug Fails 76 HER2 Positive 76 Demonstrates Potent 76 Castration Resistant Prostate Cancer 76 Osteoporosis Drugs 76 Genes Linked 76 Anti Clotting Drug 76 Oral Fingolimod 76 Artery Disease 76 Critically Ill Patients 76 Beneficial Effects 76 Randomized Trials 76 Viral Suppression 75 Blood Clots 75 Venous Thromboembolism 75 Therapy Improves 75 Phase III Clinical Trial 75 Cholesterol Drug 75 Demonstrates Efficacy 75 Lung Cancer Trial 75 Stomach Cancer 75 Phase 2a Trial 75 Increased Mortality 75 Renal Cancer 75 Rectal Cancer 75 Potentially Fatal 75 Non Inferiority 75 Obesity Linked 75 Breast Cancers 75 Shows Promising 75 Brain Atrophy 75 Meta Analysis 75 Increases Risk 75 Completes Patient Enrollment 75 Liver Failure 75 Arthritis Drug 75 Significantly Improved 75 Blood Thinner 75 Heartburn Drugs 75 Anemia Drug 75 Gout Drug 75 Study Demonstrates 75 Phase 2a Clinical Trial 75 Insulin Glargine 75 Stem Cell Transplants 75 Long Term Outcomes 75 Investigational Treatment 75 Malignant Melanoma 75 Unresectable 75 Partial Onset Seizures 75 Phase IIb Clinical Trial 75 Relapsed Refractory 75 Premature Infants 75 Treatment Regimen 75 Treatment Reduces 75 Breast Cancer Cells 75 Demonstrated Significant 75 Kidney Transplants 75 Novel Antibiotic 75 Statin Drugs 75 Receives Orphan Drug Designation 75 Carboplatin Paclitaxel 75 Multicenter Trial 74 Epilepsy Drugs 74 Chronic Hepatitis B 74 Testosterone Patch 74 Drug Coated Stents 74 Cancer Treatments 74 Migraine Drug 74 Autologous Stem Cell Transplantation 74 Severe Asthma 74 Drug Prevents 74 Carotid Stenting 74 Prostate Cancer Treatment 74 Emerging Therapies 74 Minimally Invasive Treatment 74 Hepatitis C Patients 74 Rheumatoid Arthritis Drug 74 Radiation Dose 74 Atypical Antipsychotics 74 Reduce Mortality 74 Shows Promise Against 74 Prolongs Life 74 Adverse Effects 74 Bone Metastases 74 Sustained Reduction 74 Epoetin Alfa 74 Antibiotic Use 74 Stem Cell Treatment 74 Novel Oral 74 Schizophrenia Drug 74 Zoledronic Acid 74 NDA Submission 74 Demonstrates Positive 74 Boosts Survival 74 Reduces Risk 74 Treatment Naïve 74 Immune Responses 74 Estrogen Therapy 74 Transplant Patients 74 Significantly Reduces 74 Improve Outcomes 74 Anthracycline 74 Prostate Tumors 74 Fungal Infections 74 Stent Implantation 74 Experimental Vaccine 74 Hormone Therapy 74 Tolerability 74 Renal Function 74 Anticancer Drugs 74 Metastatic Melanoma 74 Survival Rate 74 Expanded Indication 74 Newly Diagnosed Breast Cancer 74 Genetic Mutation 74 Node Positive 74 Genetic Mutations 74 Slows Progression 74 Serious Infections 74 Disease Modifying 74 Higher Doses 74 Invasive Breast Cancer 74 Acute Pancreatitis 74 Therapeutic Potential 74 Anticancer Drug 74 Hemodialysis Patients 74 Milestone Payment 74 Gene Variants 74 Commonly Used 74 Significant Improvements 74 Relapsing Remitting Multiple Sclerosis 74 Randomized Double Blind 74 Enlarged Prostate 73 Immune Cells 73 II Clinical Trial 73 Combination REOLYSIN R 73 Treatment Shows Promise 73 Rotavirus Vaccine 73 Antibiotic Treatment 73 FDA Panel Recommends 73 Cutaneous T 73 Asthma Treatment 73 Therapy Reduces 73 Less Invasive 73 First Patient Treated 73 Liver Damage 73 Significantly Improves 73 Pivotal Study 73 Preterm Delivery 73 Genes Associated 73 Treatment Resistant 73 Dose Finding 73 Controlled Trial 73 Cardiac Function 73 Glycemic Control 73 Cognitive Impairment 73 Randomized Controlled Trials 73 Interferon Beta 73 Cholesterol Levels 73 Osteoarthritis Patients 73 Tumor Cells 73 Soft Tissue Sarcoma 73 Plus Ribavirin 73 Blocked Arteries 73 Completes Enrollment 73 Diabetic Nephropathy 73 Antipsychotic Drug 73 Drug Resistant 73 Acute Coronary Syndromes 73 Randomized Phase 73 Left Ventricular Hypertrophy 73 Paclitaxel Carboplatin 73 Advanced Renal Cell 73 FDA Approves Drug 73 Chronic Myeloid Leukemia 73 Targeted Therapies 73 Prospective Randomized 73 Neuroprotective Effects 73 Potent Anti 73 Recurrent Breast Cancer 73 Platelet Inhibition 73 Protein Linked 73 Liver Metastases 73 Pulmonary Arterial Hypertension 73 Pivotal Phase 73 Psoriasis Drug 73 Contrast Agents 73 Newly Diagnosed Patients 73 Genes Predict 73 Demonstrates Potential 73 Stent Thrombosis 73 Genetic Variant 73 Endometrial Cancer 73 Menopausal Women 73 Surgical Procedures 73 Commonly Prescribed 73 Oral Cladribine 73 Postmenopausal Osteoporosis 73 Blood Pressure Lowering 73 Kidney Transplant Recipients 73 Levels Linked 73 Pharmacokinetic Study 73 Showed Significant 73 Prostate Cancer Vaccine 73 Treatment Naive HIV 73 Gastric Ulcers 73 Psoriasis Patients 73 Nymox NX 73 Sustained Efficacy 73 Dual Antiplatelet Therapy 73 FDA Clears 73 Lymph Nodes 73 Prophylactic Treatment 73 Prostate Cancer Survival 73 Fast Track Status 73 Presents Preclinical Data 73 Clinical Trial Evaluating 73 Autoimmune Disease 73 Peginterferon 73 Hypercholesterolemia 73 Treatment Naïve Patients 73 Submits NDA 73 Shingles Vaccine 73 Secondary Hyperparathyroidism 73 Erectile Dysfunction Drug 73 Inflammatory Markers 73 Cardiovascular Outcomes 73 See CLINICAL PHARMACOLOGY 73 Complete Remission 73 Physical Function 73 Benign Prostatic Hyperplasia 73 Panic Disorder 73 Pancreatic Adenocarcinoma 73 Cell Transplants 73 Diabetic Neuropathy 73 Fluorouracil 73 Teva Provides Update 72 Chronic Sinusitis 72 Pneumococcal Vaccine 72 Acute Ischemic Stroke 72 Dialysis Patients 72 Topline Results 72 Immunomedics Announces 72 Genetic Tests 72 Migraine Headaches 72 Vaccine Candidate 72 Clinical Efficacy 72 Asthma Symptoms 72 Moderate Drinking 72 Adjunctive Therapy 72 Antidepressant Use 72 Placebo Controlled Trial 72 Pegylated Interferon 72 Serious Side Effects 72 First Patient Dosed 72 Drug Eluting 72 Peginterferon Alfa 2a 72 Patient Outcomes 72 Novel Mechanism 72 Complicated Skin 72 Pivotal Phase III 72 Positive Opinion 72 Treatment Experienced 72 Anemia Drugs 72 Cocaine Addiction 72 Antiviral Drugs 72 Prostate Cancers 72 Pivotal Trials 72 Lipid Levels 72 Hepatocellular Carcinoma 72 Reduces Mortality 72 Initiate Clinical Trial 72 Colorectal Adenomas 72 Refractory Hodgkin Lymphoma 72 Non Responders 72 Skin Cancers 72 Vaginal Gel 72 Metastatic Pancreatic Cancer 72 Treating Depression 72 Colorectal Cancer Risk 72 Patients Enrolled 72 Bipolar Depression 72 Elevated Levels 72 Naive Patients 72 Spectrum Pharmaceuticals Announces 72 CYPHER R Sirolimus Eluting 72 Allergic Reactions 72 Chronic Constipation 72 Shows Promise 72 Skeletal Muscle 72 ST Elevation Myocardial 72 Phase 1b Clinical Trial 72 Genes Identified 72 Vaccine Adjuvant 72 Blood Cancers 72 FDA Clearance 72 Peginterferon Alfa 2b 72 Randomized Study 72 Pre Cancerous 72 Regimens 72 Prostate Biopsy 72 Granted Orphan Drug 72 Severe Acne 72 Drug Coated Stent 72 Potent Antiviral Activity 72 Gum Disease 72 Clot Risk 72 Double Blind Placebo 72 Immunosuppression 72 Prognostic Value 72 ORLive Presents 72 Colorectal Cancers 72 Follicular Lymphoma 72 Generic Version 72 NICE Recommends 72 Lung Cancers 72 Randomized Clinical Trial 72 Inhaled Nitric Oxide 72 Obese Teens 72 Brain Scans 72 Therapy Shows Promise 72 Neoadjuvant 72 Ischemic Stroke 72 Skin Lesions 72 Intracerebral Hemorrhage 72 Blood Pressure Drugs 72 Antiviral Activity 72 Heart Stents 72 Bone Marrow Cells 72 Beta Blocker 72 Hepatitis C Treatment 72 Orally Active 72 Solid Tumors 72 Randomized Clinical Trials 72 Poorly Controlled 72 Bevacizumab 72 Primary Endpoint 72 Glatiramer Acetate 72 Pivotal Trial 72 Hematological Cancers 72 Prove Effective 72 Radiofrequency Ablation 72 Treating Chronic 72 Progressive Multifocal Leukoencephalopathy 72 Chronic Cough 71 Nicotine Vaccine 71 Comorbidities 71 Renal Anemia 71 Trial Evaluating 71 Often Misdiagnosed 71 Weight Loss Drug 71 Antipsychotic Medications 71 Significant Efficacy 71 Antidepressants Linked 71 Subtypes 71 Blood Clot Risk 71 Symptom Improvement 71 Allergic Rhinitis 71 Renal Impairment 71 Test Detects 71 Diuretic 71 Therapeutic Efficacy 71 ACE Inhibitors 71 Statistical Significance 71 Pregnancy Linked 71 Capsules CII 71 Genetic Variants 71 Liver Tumors 71 Anticoagulant 71 Glucose Levels 71 Androgen Deprivation 71 RNAi Therapeutic 71 Kidney Failure 71 Receives Positive Opinion 71 Hepatitis B Vaccine 71 Metabolic Disorder 71 Genetic Predisposition 71 Breast Density 71 Study Shows Benefits 71 Efficacy Trial 71 Glucose Control 71 Blood Pressure Reduction 71 Hemoglobin Levels 71 Lung Cancer Risk 71 Antiplatelet Therapy 71 Treatment Naive 71 Bladder Cancer 71 Prostate Surgery 71 Bypass Surgery 71 Prevent Stroke 71 BioElectronics Announces 71 Bipolar Mania 71 Male Contraceptive 71 First Patient Enrolled 71 Pain Relievers 71 Tiotropium 71 Novel Inhibitor 71 Abdominal Pain 71 Meet Primary Endpoint 71 Ovary Removal 71 Genetic Disorder 71 Confirms Efficacy 71 Cholesterol Lowering 71 Study Shows Significant 71 Certain Cancers 71 Bone Mineral Density 71 Oral Presentations 71 Hematological Malignancies 71 Testosterone Levels 71 Effectively Treats 71 Blood Vessels 71 Gastrointestinal Disorders 71 Antipsychotic Drugs 71 Reduces Pain 71 Tyrosine Kinase Inhibitor 71 Cholesterol Lowering Drugs 71 Endovascular Treatment 71 Inhaled Insulin 71 Initiates Clinical Trial 71 Lupus Nephritis 71 TNF Blockers 71 Diabetic Neuropathic Pain 71 Initiate Phase III 71 Plaque Psoriasis 71 Acute Heart Failure 71 Gene Therapy Trial 71 Antitumor 71 Patient Treated 71 Guidelines Recommend 71 FDA Accepts 71 R Bortezomib 71 Demonstrates Sustained 71 Cancer Cells 71 Study Evaluates 71 Advanced Solid Tumors 71 Transdermal Patch 71 Randomized Phase II 71 Painkiller Abuse 71 Successfully Treated 71 Viral Infections 71 Brentuximab Vedotin SGN 71 Blood Transfusions 71 Study Indicates 71 Bone Fracture 71 Nilotinib 71 Prostate Cancer Surgery 71 Preclinical Models 71 Cognitive Decline 71 Diagnostic Tests 71 Cardiotoxicity 71 Tumor Response 71 Gout Patients 71 Generic Versions 71 Hepatitis C Infection 71 Pegylated 71 Strongly Linked 71 Beta Blockers 71 Cervical Dysplasia 71 Bloodstream Infections 71 Randomised Trial 71 Hepatitis C Genotype 71 Liver Toxicity 71 Fixed Dose 71 Total Knee Arthroplasty 71 Treat Heart Failure 70 Cardiac Resynchronization 70 Bivalirudin 70 Iron Overload 70 Cognitive Function 70 Hyperlipidemia 70 Liver Injury 70 Mayo Clinic Study Finds 70 Protease Inhibitor 70 Predict Prostate Cancer 70 Cardiovascular Disease Risk 70 Statistically Significant Improvement 70 Phase III Clinical Trials 70 Calcium Vitamin D 70 Pegylated Liposomal Doxorubicin 70 Cell Lymphoma 70 Sipuleucel T 70 Vildagliptin 70 Lung Function 70 Lower Blood Pressure 70 Myocardial Ischemia 70 Hip Replacement Surgery 70 Mortality Risk 70 Fondaparinux 70 Immune Cell 70 Inflammatory Disease 70 Oral Mucositis 70 Insulin Resistance 70 Aurora Kinase 70 Lymph Node 70 Fulvestrant 70 Smoking Linked 70 Files IND 70 Deep Venous Thrombosis 70 Bone Fractures 70 Prolonged Survival 70 Darbepoetin Alfa 70 Epratuzumab 70 Virus Linked 70 Controlled Study 70 Heart Attacks 70 Depressive Symptoms 70 Initiates Phase III 70 Predict Response 70 Genetic Variations 70 Hip Fractures 70 Virus Infection 70 Respiratory Distress 70 Trial Halted 70 Intravenous Formulation 70 Venous Thrombosis 70 Colon Polyps 70 Lowers Blood Pressure 70 Allogeneic 70 Treatment Regimens 70 Clostridium difficile Infection 70 Tremendous Growth 70 Stronger Warnings 70 Sleep Disturbances 70 Efficacy Results 70 Cigarette Smoke 70 Mylan Receives Approval 70 Antipsychotic 70 Receives Orphan Drug 70 Shown Effective 70 Fibromyalgia Pain 70 Hepatitis C Virus 70 Brain Tumors 70 Therapeutic Vaccines 70 Diagnostic Criteria 70 Smallpox Vaccine 70 Vitamin D Linked 70 Capecitabine 70 Ovarian Cancer Treatment 70 Diabetic Kidney Disease 70 Protease Inhibitors 70 Breast Cancer Stem Cells 70 Receives Approvable Letter 70 Ovarian Cancers 70 Study Shows Promise 70 Technological Advances 70 Induces 70 Who Underwent 70 Antidepressant Drug 70 Lung Tumors 70 Inhaled Steroids 70 Organ Rejection 70 Prostate Cancer Recurrence 70 Epidermal Growth Factor Receptor 70 Mouse Models 70 Gastric Bypass Surgery 70 Novel Compounds 70 Drug Combinations 70 Spinal Fractures 70 Kinase Inhibitor 70 Pharmacyclics Announces 70 Drug Maker 70 Abiraterone Acetate 70 IND Filing 70 Pivotal Clinical Trial 70 Viral Load 70 Receives Fast Track 70 Gemcitabine 70 Fat Cells 70 Golimumab 70 Effective Treatments 70 Renal Tumors 70 Hematopoietic Stem Cell Transplantation 70 Molecular Diagnostic Test 70 Thyroid Hormone 70 Vaccine Protects Against 70 Blood Thinning 70 Genetic Defect 70 Cardiogenic Shock 70 Guidelines Issued 70 Prevent Fractures 70 Drug Resistant TB 70 Inhibits 70 Confirmatory Phase 70 Laryngeal Cancer 70 Glufosfamide 70 Breast Cancer Risk 70 Treatable 70 Hsp# Inhibitor 70 Acute Migraine 70 Clinically Significant 70 Nearly Doubled 70 Prognostic Significance 70 Chronic Lymphocytic Leukemia 70 Arthritis Drugs 70 Recombinant Human 70 Cause Mortality 70 Viral Infection 70 Abortion Pill 70 Preterm Infants 70 Novel Treatments 70 Predict Breast Cancer 70 Topical Treatment 70 Uterine Fibroid Embolization 70 Suicidal Thoughts 70 Smooth Muscle 70 Protein Involved 70 Carcinomas 70 Lung Cancer Treatment 70 Could Predict 70 Phase IIa Clinical Trial 70 Flu Strains 70 Cervical Cancer Vaccine 70 Spinal Fusion 70 Oral Formulation 70 Urinary Incontinence 70 Oral Calcitonin 70 Radiation Exposure 70 Adefovir 70 Placebo Controlled Study 70 Life Threatening 70 Leukemias 70 Cancer Diagnosis 70 Phospholipase A2 69 Calcium Supplements 69 Chronic Inflammation 69 Dementia Risk 69 Bortezomib 69 ST Segment Elevation 69 CHMP Opinion 69 Lowering Blood Pressure 69 Treating Heart Failure 69 Catheter Ablation 69 Improves Quality 69 Tezampanel 69 achieved CCyR 69 Atypical Hemolytic Uremic Syndrome 69 Successfully Completes Phase 69 Randomized Controlled Trial 69 Septic Shock 69 Prognostic Factors 69 Stent Restenosis 69 Diet Pill 69 Preterm Labor 69 Pharmacodynamics 69 Advanced Gastric Cancer 69 Biologic Drugs 69 Breast Tumor 69 Thyroid Cancer 69 Useful Tool 69 Low Doses 69 Silicone Breast Implants 69 Carotid Endarterectomy 69 Significant Reductions 69 Help Predict 69 Receives Milestone Payment 69 Irregular Heartbeat 69 Reduce Risk 69 Dose Ranging 69 Novel Therapeutic 69 Bone Marrow Transplants 69 Study Casts Doubt 69 Lymphoma Patients 69 Genetic Variation 69 Abdominal Fat 69 Clinically Tested 69 Dendritic Cells 69 Breast Tissue 69 Lung Transplants 69 Surgery Performed 69 Bosutinib 69 Adenoma 69 Node Negative 69 Placebo Effect 69 Small Molecule 69 Paraplatin ® 69 Study Proves 69 Heart Transplant Recipients 69 Initiates Enrollment 69 Muscle Function 69 Metastatic Cancer 69 Stem Cell Procedure 69 Study Confirms 69 Develop Novel 69 Chronic Stress 69 Demonstrate Significant 69 Contrast Agent 69 Million Cribs Recalled 69 Spinal Manipulation 69 Sangamo BioSciences Announces 69 Treat Anemia 69 Adverse Outcomes 69 Prevent Breast Cancer 69 Liver Transplants 69 Dosage Forms 69 Trastuzumab 69 Impairs 69 Randomized Controlled 69 Monoclonal Antibody 69 Hedgehog Pathway 69 Acne Drug 69 Blood Thinners 69 Aliskiren 69 Oral Anticoagulant 69 Brain Cells 69 Erlotinib 69 Brain Aneurysms 69 Clot Busting 69 Muscle Wasting 69 MRSA Infections 69 AVI BioPharma Announces 69 Ample Supply 69 Kinase Inhibitors 69 Taxane 69 Early Diagnosis 69 Symptom Relief 69 Blood Disorder 69 MEK Inhibitor 69 Pulmonary Artery 69 Lung Infection 69 Eluting Stent 69 Cognitive Deficits 69 Could Prevent 69 Phase III Pivotal Trial 69 Ovarian Cancer Risk 69 Severe Psoriasis 69 Breast Cancer Tumors 69 Gender Differences 69 Prostate Cancer Risk 69 Hormone Replacement 69 Left Ventricular 69 Minimally Invasive Procedure 69 Interferon Gamma 69 Tumor Targeting 69 Being Studied 69 Breathing Problems 69 Systemic Delivery 69 Poniard Pharmaceuticals Announces 69 Lung Cancer Surgery 69 Diffuse Large B 69 Radioimmunotherapy 69 Abstracts Accepted 69 Cancer Patients Treated 69 Endothelial Function 69 Radiation Induced 69 Menopausal Symptoms 69 Relapsed Refractory Aggressive 69 Suicidality 69 Circulating Tumor Cells 69 Active Rheumatoid Arthritis 69 Chronic Heart Failure 69 Bisphosphonate 69 Recurrent Ovarian Cancer 69 Esophageal Cancer 69 Migraine Pain 69 Presents Positive 69 Hepatotoxicity 69 Medoxomil 69 Randomized Double blind 69 Initiates Clinical Trials 69 Own Stem Cells 69 Hospital Acquired Pneumonia 69 Preclinical Efficacy 69 Dose Ranging Study 69 Urine Test 69 Bacterial Infection 69 Attenuates 69 Diabetic Foot Ulcer 69 ER Visits 69 Widely Used 69 Non Invasive Treatment 69 Leukemia Cells 69 Antifungal 69 Oral Laquinimod 69 Results Confirm 69 Pain Medications 69 Periodontal Disease 68 Ebola Vaccine 68 Malaria Vaccine 68 Chemotherapeutic Agents 68 Sleep Duration 68 RNAi Therapeutics 68 Iron Deficiency 68 Gastrointestinal Stromal Tumors 68 Fully Prepared 68 Prostate Cancer Treatments 68 Immunogenic 68 Anti Inflammatory Drug 68 Hormonal Therapy 68 Generic Erosion 68 Successfully Treats 68 Inflammatory Arthritis 68 Acute Myocardial Infarction 68 Potentially Deadly 68 CT Angiography 68 Synthetic Peptide 68 Genes Involved 68 Mg Usa 68 Osteoarthritis Knee Pain 68 Breast Cancer Metastasis 68 Opioid Use 68 Insulin Sensitivity 68 Tablet Formulation 68 Drug Makers 68 Renal Cell Cancer 68 Hospitalization Rates 68 Detect Cancer 68 PRN FDA Approves 68 Fludarabine 68 Lowers Cholesterol 68 Sirolimus Eluting 68 Safinamide 68 Inflammatory Diseases 68 Data Indicate 68 EntreMed Presents 68 Robotic Assisted 68 Initiates Clinical 68 Combination Clinical Trial 68 Autoimmune Diseases 68 Key Milestones 68 Unmet Medical 68 Breast Cancer Treatments 68 Parathyroid Hormone 68 Mitral Regurgitation 68 Gene Mutation Linked 68 Flu Vaccines 68 Lung Cancer Deaths 68 Statin Use 68 Endothelial Cells 68 Blood Clotting 68 DOR BioPharma Announces 68 Vaccine Shows Promise 68 Telaprevir VX 68 Pregnancy Complication 68 Sinus Infections 68 Novel Compound 68 Overweight Obese 68 Schizophrenia Treatment 68 Peanut Allergies 68 Mycophenolate Mofetil 68 IND Application